نتائج البحث - Kaniel Cassady

  • يعرض 1 - 10 نتائج من 10
تنقيح النتائج
  1. 1
    TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair

    TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair حسب Yimei Feng, Xiaoping Li, Kaniel Cassady, Zhongmin Zou, Xi Zhang

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside

    The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside حسب Yimei Feng, Xiaoli Chen, Kaniel Cassady, Zhongmin Zou, Shijie Yang, Zheng Wang, Xi Zhang

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Increased Expression of System xc− in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance

    Increased Expression of System xc− in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance حسب Monika D. Polewski, Rosyli F. Reveron‐Thornton, Gregory Cherryholmes, Georgi K. Marinov, Kaniel Cassady, Karen S. Aboody

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    B7H1/CD80 Interaction Augments PD-1–Dependent T Cell Apoptosis and Ameliorates Graft-versus-Host Disease

    B7H1/CD80 Interaction Augments PD-1–Dependent T Cell Apoptosis and Ameliorates Graft-versus-Host Disease حسب Ruishu Deng, Kaniel Cassady, Xiaofan Li, Sheng Yao, Mingfeng Zhang, Jeremy J. Racine, Jeffrey Lin, Lieping Chen, Defu Zeng

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice

    Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice حسب Hua Jin, Xiong Ni, Ruishu Deng, Qingxiao Song, James S. Young, Kaniel Cassady, Mingfeng Zhang, Stephen J. Forman, Paul J. Martin, Qifa Liu, Defu Zeng

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells

    PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells حسب Xiong Ni, Qingxiao Song, Kaniel Cassady, Ruishu Deng, Hua Jin, Mingfeng Zhang, Haidong Dong, Stephen J. Forman, Paul J. Martin, Yuanzhong Chen, Jianmin Wang, Defu Zeng

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity

    Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity حسب Yuankun Zhang, Qingxiao Song, Kaniel Cassady, Michael Lee, Haidong Tang, Moqian Zheng, Bixin Wang, Dustin E. Schones, Yang‐Xin Fu, Arthur D. Riggs, Paul J. Martin, Ru Feng, Defu Zeng

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study

    Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study حسب Yimei Feng, Yunshuo Xiao, Hongju Yan, Ping Wang, Wen Zhu, Kaniel Cassady, Zhongmin Zou, Kaifa Wang, Ting Chen, Yao Quan, Zheng Wang, Shijie Yang, Rui Wang, Xiaoping Li, Lei Gao, Cheng Zhang, Yao Liu, Peiyan Kong, Li Gao, Xi Zhang

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial

    Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial حسب Lei Gao, Yanqi Zhang, Sanbin Wang, Peiyan Kong, Yi Su, Jiong Hu, Ming Jiang, Hai Bai, Tao Lang, Jishi Wang, Li Liu, Tonghua Yang, Xiaobing Huang, Fang Liu, Shifeng Lou, Yao Liu, Cheng Zhang, Hong Liu, Li Gao, Jia Liu, Lidan Zhu, Wen Qin, Ting Chen, Ping Wang, Jun Rao, Min Mao, Cunbang Wang, Xianlin Duan, Le Luo, Xiangui Peng, Kaniel Cassady, Jiang F. Zhong, Xi Zhang

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

    Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma حسب Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C. Lee, James E. Hoffman, Attaya Suvannasankha, Jeffrey A. Zonder, Mansi Shah, Suzanne Lentzsch, Rachid Baz, Joseph Maly, Swathi Namburi, Matthew J. Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca Silbermann, Chang‐Ki Min, Marie‐Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez‐López, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D. Yancopoulos, L. Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S. Kroog, Yariv Houvras, Madhav V. Dhodapkar

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: